LIVMARLI

Product Overview

About LIVMARLI

LIVMARLI is a prescription medication containing the active ingredient Maralixibat (Maralixibat Chloride), a bile acid transport inhibitor. It is used to treat cholestasis in patients with Alagille syndrome or primary sclerosing cholangitis.

Key Benefits & Uses

• Treatment of cholestasis in patients with Alagille syndrome
• Treatment of cholestasis in patients with primary sclerosing cholangitis
• Improvement of liver function and reduction of bile acid levels

Active Ingredient & Action

Maralixibat (Maralixibat Chloride) works by inhibiting the bile acid transport protein, which helps to reduce bile acid levels in the liver and improve liver function. This can lead to improved symptoms and quality of life for patients with cholestasis.

Important Notes

LIVMARLI is available by prescription only and should be used under the guidance of a healthcare professional. Patients should be monitored for potential side effects, including diarrhea, abdominal pain, and elevated liver enzymes. It is essential to follow the recommended dosage and usage instructions to ensure safe and effective treatment.